RegisterLogin

GZD-257

CAT: 0804-HY-178969Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-178969Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
GZD-257 is a brain-penetrant, ATP-competitive FAK inhibitor (IC50 = 14.3 nM), performing 4.77-fold selectivity with FAK to Pyk2 (IC50 = 68.2 nM) . GZD-257 can significantly induce apoptosis of U118MG cells and arrest the cell cycle at the G2/M phase. GZD-257 can be used for the study of Glioblastoma (GBM) [1].
UNSPSC
12352005
Target
Apoptosis; FAK; Pyk2
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Field of Research
Cancer; Neurological Disease
Smiles
ClC(C=N1)=C(NC2=CC3=CC=C2C(NC)=O)N=C1NC(C=C4)=CC(OCCCCO3)=C4N5CCOCC5
Molecular Formula
C26H29ClN6O4
Molecular Weight
525.00
References & Citations
[1]Wu T, et al. Discovery of a macrocyclic FAK inhibitor GZD-257 for treatment of glioblastoma. Bioorg Med Chem Lett. 2025 Oct 2;130:130424.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-122630-01TH-257
HY-111155RBI-257 (maleate)
HY-169906Anticancer agent 257
HY-W953399CRBN ligand-257
HY-15010-01L-371,257
HY-P1489-01OVA Peptide (257-264)
HY-P5400-01OVA (257-264), scrambled
HY-P1489F-01FAM-OVA (257-264)
HY-P4033HCV Peptide (257-266)
HY-P1489A-01OVA Peptide (257-264) (TFA)

Alternative Products

CatalogName
MBS3607906-01GZD 824
MBS3610824-01TH 257
MBS3846858-01TH-257
255013-01CLP 257
sc-200666ABML-257
RM-P190557-01Posaconazole Impurity 257
RM-V151857-01Vonoprazan Impurity 257
RM-T140857-01Tenofovir Impurity 257
MBS5778183RBI-257 Maleate
SB031-5MGOva 257 264

Popular Products